CSS LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-56,800
| Closed | -$6.57M | – | 1022 |
|
|
2023
Q3 | $6.57M | Buy |
56,800
+39,800
| +234% | +$4.28M | 0.43% | 47 |
|
|
2023
Q2 | $1.75M | Buy |
+17,000
| New | +$1.79M | 0.11% | 148 |
|
|
2021
Q1 | – | Sell |
-7,800
| Closed | -$571K | – | 1256 |
|
|
2020
Q4 | $571K | Sell |
7,800
-32,300
| -81% | -$2.4M | 0.02% | 430 |
|
|
2020
Q3 | $3.12M | Sell |
40,100
-12,100
| -23% | -$833K | 0.15% | 138 |
|
|
2020
Q2 | $2.9M | Buy |
52,200
+18,400
| +54% | +$787K | 0.16% | 137 |
|
|
2020
Q1 | $1M | Buy |
33,800
+21,500
| +175% | +$727K | 0.08% | 204 |
|
|
2019
Q4 | $445K | Hold |
12,300
| – | – | 0.02% | 374 |
|
|
2019
Q3 | $335K | Buy |
12,300
+1,800
| +17% | +$46.5K | 0.02% | 365 |
|
|
2019
Q2 | $253K | Sell |
10,500
-56,400
| -84% | -$1.43M | 0.01% | 408 |
|
|
2019
Q1 | $1.77M | Buy |
66,900
+28,900
| +76% | +$685K | 0.11% | 141 |
|
|
2018
Q4 | $742K | Hold |
38,000
| – | – | 0.05% | 240 |
|
|
2018
Q3 | $744K | Hold |
38,000
| – | – | 0.03% | 261 |
|
|
2018
Q2 | $629K | Hold |
38,000
| – | – | 0.03% | 272 |
|
|
2018
Q1 | $540K | Sell |
38,000
-200
| -0.5% | -$2.96K | 0.03% | 300 |
|
|
2017
Q4 | $558K | Hold |
38,200
| – | – | 0.03% | 332 |
|
|
2017
Q3 | $484K | Hold |
38,200
| – | – | 0.02% | 357 |
|
|
2017
Q2 | $453K | Buy |
38,200
+38,000
| +19,000% | +$473K | 0.02% | 368 |
|
|
2017
Q1 | $3K | Sell |
200
-1,000
| -83% | -$16.2K | ﹤0.01% | 626 |
|
|
2016
Q4 | $19K | Hold |
1,200
| – | – | ﹤0.01% | 671 |
|
|
2016
Q3 | $22K | Buy |
1,200
+200
| +20% | +$3.91K | ﹤0.01% | 696 |
|
|
2016
Q2 | $16K | Sell |
1,000
-30,000
| -97% | -$485K | ﹤0.01% | 683 |
|
|
2016
Q1 | $514K | Sell |
31,000
-31,000
| -50% | -$542K | 0.03% | 332 |
|
|
2015
Q4 | $1.34M | Buy |
62,000
+52,000
| +520% | +$1.01M | 0.08% | 204 |
|
|
2015
Q3 | $198K | Buy |
+10,000
| New | +$316K | 0.01% | 587 |
|
Other funds holding HZNP
CSS LLC's HZNP Position: Q4 2023 in Review
CSS LLC sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 32,276 shares — an estimated $3.73M sold.
CSS LLC first reported a position in HZNP in Q4 2015 and held it in 15 quarters. The position peaked at $8.33M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.
- CSS LLC reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- CSS LLC sold 32,276 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $3.73M.
- CSS LLC first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 15 quarters.
- CSS LLC's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $8.33M in Q3 2020.
- 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.
Based on CSS LLC's 13F filing for Q4 2023, filed 14 Feb 2024.